Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension.

Shiratori, Naka; Nishio, Yusuke; Takeda, Ayaka; Sugimoto, Shio; Takazawa, Kenji; Otsuka, Naomi; Ishida, Naruhiro; Shii, Daisuke; Hori, Kiyotaka; Nakamoto, Kenji

Shiratori, Naka; Nishio, Yusuke; Takeda, Ayaka; Sugimoto, Shio; Takazawa, Kenji; Otsuka, Naomi; Ishida, Naruhiro; Shii, Daisuke; Hori, Kiyotaka; Nakamoto, Kenji.

Afiliação

Shiratori N; Department of Ophthalmology, Nippon Medical School, Tokyo, Japan.
Nishio Y; Shinanozaka Clinic, Tokyo, Japan.
Takeda A; Department of Ophthalmology, Nippon Medical School, Tokyo, Japan.
Sugimoto S; Shinanozaka Clinic, Tokyo, Japan.
Takazawa K; Department of Ophthalmology, Nippon Medical School, Tokyo, Japan.
Otsuka N; Shinanozaka Clinic, Tokyo, Japan.
Ishida N; Department of Ophthalmology, Nippon Medical School, Tokyo, Japan.
Shii D; Shinanozaka Clinic, Tokyo, Japan.
Hori K; Shinanozaka Clinic, Tokyo, Japan.
Nakamoto K; Japan Medical Affairs Group, Santen Pharmaceutical Co. Ltd., Osaka, Japan.